What Biofarm does

Biofarm S.A. is a Romanian pharmaceutical manufacturer, established in 1921 and headquartered in Bucharest, that produces medicines and food supplements. The company is listed on the Bucharest Stock Exchange under the ticker BVB:BIO and operates with between 251 and 500 employees. Its product portfolio spans registered pharmaceutical medicines and consumer health food supplements, sold through Romania's pharmacy, hospital, and distribution channels typical of a domestic generics producer.

The business is owned in part by Longshield Investment Group SA and Lion Capital S.A., alongside other public shareholders. On May 6, 2026, Polpharma SA Pharmaceutical Works — a larger European generics operator — launched a voluntary tender offer to acquire Biofarm S.A. from these shareholders for RON 1.4 billion, equating to RON 1.379 per share in cash, a premium of roughly 15 percent over the prevailing market price. The transaction is subject to approval by the Romanian Financial Supervisory Authority, and a special dividend of RON 0.140263 per share is intended to be distributed to shareholders ahead of the tender offer launch. Biofarm's shares rose 2.9 percent on May 7, 2026 following the announcement.

Day-to-day operations are led by Catalin Vicol, who serves as Chief Executive Officer, General Manager, and Board Member. On completion of the Polpharma transaction, Biofarm would become a subsidiary of Polpharma SA Pharmaceutical Works, transitioning from public to private ownership under a larger strategic operator in the European generics market.

Name

Biofarm

Legal name

Biofarm S.A.

Website

https://biofarm.ro

Company type

Public

Founded year

1921

Operating status

Operating

Headcount range

251–500 employees

Short description

Biofarm S.A. is a Romanian pharmaceutical manufacturer, founded in 1921 and listed on the Bucharest Stock Exchange (BVB:BIO), producing medicines and food supplements for the Romanian domestic market and currently subject to a voluntary tender offer from Polpharma SA Pharmaceutical Works.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Pharmaceutical manufacturing
• Food supplements
• OTC medicines
• Consumer healthcare
• Romanian pharmaceuticals

Headquarters

HQ city

Bucharest

HQ country

Romania

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D

Core offering

Biofarm is a Romanian pharmaceutical manufacturer founded in 1921 that produces and sells medicines and food supplements. The company manufactures over-the-counter (OTC) medicines and dietary supplements through its own production facilities in Bucharest, distributing its products through pharmacies and retail drug stores in Romania and surrounding markets.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• STADA Arzneimittel: European-focused generic and consumer healthcare company; comparable to Biofarm as a generics-plus-supplements business, though operating at materially greater scale across multiple European markets.
• Polpharma: Largest Polish pharmaceutical manufacturer and the announced acquirer of Biofarm; comparable as a broad CEE generics and OTC player with significantly greater scale, product breadth, and international reach.

Direct peers

• KRKA: Slovenian generic pharmaceutical producer with an established CEE and Eastern European distribution network; competes with Biofarm in similar generic and OTC categories across overlapping markets.
• Alvogen: US-headquartered with significant Central and Eastern European generic pharmaceutical operations; directly comparable to Biofarm in generics portfolio and CEE distribution channels.
• Terapia (Sun Pharma Romania): Romanian generic and OTC pharmaceutical operation of Sun Pharma, directly competing with Biofarm in the domestic generics and supplements market.
• Gedeon Richter: Hungary-based branded and generic pharmaceutical manufacturer with a similar CEE footprint and product breadth, comparable to Biofarm in therapeutic-area coverage and Central European commercial model.
• Zentiva: Pan-European generic and OTC pharmaceutical manufacturer headquartered in Prague with strong CEE presence, directly comparable to Biofarm in product mix, generic-and-supplement positioning, and regional distribution model.
• Antibiotice Iasi: Romanian pharmaceutical manufacturer producing generics, OTC, and supplements; directly comparable to Biofarm as a same-country peer with overlapping product categories and channel mix.

Regional players

• Fiterman Pharma: Romanian pharmaceutical and dietary supplement manufacturer with overlapping product categories (OTC and supplements); comparable as a same-geography peer focused on Romanian retail and pharmacy channels.
• Wörwag Pharma: German-based mid-sized pharmaceutical company with strong CEE commercial presence in generics and supplements, comparable to Biofarm in product positioning and Eastern European go-to-market focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/BiofarmRomania

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biofarm